Julie Scott, DNP
Julie Scott, DNP
Amyloidosis | cancerGO

What is Amyloidosis?

Amyloidosis is a rare condition that occurs when an abnormal protein, called amyloid, builds up in the body’s organs and tissues. Over time, this buildup can cause damage and lead to organ failure. Here’s an overview of the symptoms, diagnosis, and treatment of amyloidosis.


The symptoms of amyloidosis can vary depending on which organs or tissues are affected. Some common symptoms include:

  • Fatigue
  • Shortness of breath
  • Swelling in the ankles and legs
  • Numbness or tingling in the hands or feet
  • Weight loss
  • Diarrhea or constipation
  • Enlarged tongue
  • Skin changes
  • Irregular heartbeat
  • Kidney problems


To diagnose amyloidosis, a doctor will perform a physical exam, review the patient’s medical history, and order various tests. These may include:

  • Blood tests to measure levels of abnormal proteins and assess the function of organs such as the kidneys and liver
  • Urine tests to check for abnormal proteins and assess kidney function
  • Imaging tests such as X-rays, CT scans, or MRI scans to visualize the organs and tissues
  • Biopsy, where a sample of tissue is taken from the affected area and examined under a microscope to look for signs of amyloid deposits


The treatment for amyloidosis depends on the type of amyloidosis, the extent of organ damage, and the patient’s overall health. The goal of treatment is to slow down or stop the progression of the disease and manage symptoms. Some common treatments for amyloidosis include:

  • Chemotherapy: Chemotherapy drugs may be used to kill off the abnormal cells that produce amyloid deposits.
  • Immunomodulatory drugs: These drugs help regulate the immune system and may help slow down the production of amyloid.
  • Stem cell transplant: In some cases, a patient may receive high-dose chemotherapy and then a stem cell transplant to help rebuild healthy blood cells.
  • Organ transplant: For patients with advanced organ damage, an organ transplant may be necessary to replace the damaged organ.
  • Supportive care: Other treatments may be used to manage symptoms such as pain, swelling, and organ dysfunction. These may include medications, dietary changes, and other supportive therapies.


The prognosis for amyloidosis depends on many factors, including the type of amyloidosis, the extent of organ damage, and the patient’s overall health. Some types of amyloidosis are more aggressive and may have a poorer prognosis. In general, early detection and treatment are important for improving the outlook of people living with amyloidosis.


Julie Scott, DNP
Julie Scott, DNP
Julie is an oncology certified Oncology Nurse Practitioner with over a decade of medical oncology experience. In addition to her clinical work, she is an accomplished healthcare writer providing oncology content for various publications. She also serves as an adjunct faculty member for a Master's nursing program and a chair for Doctoral nursing students.

Download our
mobile app

Share this post
You may also like
Mental Health Support During Cancer Care
March 13, 2023

Cancer is a devastating illness that affects not only the physical health of an individual but also their mental health. The diagnosis of cancer can be overwhelming, causing feelings of fear, anxiety, and depression. The treatment process can also be grueling, causing additional stress, exhaustion, and feelings of hopelessness. While…

Jenni Daniel BSN, RN


Colorectal cancer treatment (CRC)
November 8, 2022

Treatment is often classified into local therapy or systemic therapy. Local therapy means that it only treats the colon or rectum, and not any other parts of the body. Systemic therapy is treatment that goes around your entire body, treating cancer cells that may be present outside of the colon.…

Julie Scott, DNP


What is mantle cell lymphoma?
December 22, 2022

Mantle cell lymphoma is a type of non-Hodgkin's lymphoma cancer that grows in the lymphatic system. The lymphatic system is responsible for moving fluids around the body and transporting the immune system. Mantle cell lymphoma is not common and is responsible for less than 10% of lymphoma diagnoses. It’s most…

Julie Scott, DNP


cancerGO gives you access to a community

Where are people to listen, answer questions, share information, and offer valuable and timely advice